To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Amgen Inc.

(AMGN), Thousand Oaks, Calif.

Business: Biopharmaceuticals

Morgan Stanley analyst Caroline Copithorne raised her rating to "overweight" from "equal weight" and

Read the full 220 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE